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Site-directed mutagenesis of squalene^hopene cyclase:
altered substrate speci¢city and product distribution
Tongyun Dang and Glenn D Prestwich
Background: Two regions of squalene^hopene cyclase (SHC) were examined to
de¢ne roles for motifs posited to be responsible for initiation and termination of the
enzyme-catalyzed polyole¢nic cyclizations. Speci¢cally, we ¢rst examined the
triple mutant of the DDTAVV motif, a region deeply buried in the catalytic cavity
and thought to be responsible for the initiation of squalene cyclization. Next, four
mutants were prepared for Glu45, a residue close to the substrate entrance
channel proposed to be involved in the termination of the cyclization of squalene.
Results: The DDTAVV motif in SHC was changed to DCTAEA, the
corresponding conserved region of eukaryotic oxidosqualene cyclase (OSC), by
the triple mutation of D377C/V380E/V381A; selected single mutants were also
examined. The triple mutant showed no detectable cyclization of squalene, but
effectively cyclized 2,3-oxidosqualene to give mono- and pentacyclic triterpene
products. Of the Glu45 mutants, E45A and E45D showed reduced activity, E45Q
showed slightly increased activity, and E45K was inactive. A normal yield of
pentacyclic products was produced, but the ratio of hopene 2 to hopanol 3 was
signi¢cantly changed in the less active mutants.
Conclusions: Initiation and substrate selectivity may be determined by the
interaction of the DDTAVV motif with the isopropylidene of squalene (for SHC)
and of the DCTAEA motif with the epoxide of oxidosqualene (for OSC). This is the
¢rst report of a substrate switch determined by a central catalytic motif in a
triterpenoid cyclase. At the termination of cyclization, the product ratio may be
largely controlled by Glu45 at the entrance channel to the active site.
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Introduction
Squalene^hopene cyclases (SHCs) and oxidosqualene
cyclases (OSCs) are the key enzymes in triterpenoid
biosynthesis that convert the acyclic precursors squalene
(1) and (3S)-2,3-oxidosqualene (OS, 4a) to polycyclic
products (Figure 1) [1,2]. These intriguing regio- and
stereospeci¢c polyole¢nic cyclizations [3^5] have been a
focus for biological chemists seeking selective new mech-
anistic insights and medicinal chemists developing se-
lective inhibitors as potential hypocholesteremic drugs
[1,2,6].
Cyclization is believed to proceed through a series of dis-
crete conformationally rigid, partially cyclized carbocationic
intermediates [1,5]. Overall, the theme of ‘template, trig-
ger, chaperone, and sequester’ is maintained in both cy-
clases [7]. The substrate ¢rst binds to the enzyme by
adopting a speci¢c ‘product-like’ conformation and then
triggers cation formation by protonation of a double bond
or an epoxide. Next, the cyclase acts as a chaperone for
reactive carbocationic intermediates as they undergo se-
quential ring closure and rearrangement reactions; during
this process, cyclization intermediates are sequestered and
stabilized [7,8], a process that involves Z^cation interac-
tions [9,10], as discussed by Dougherty [11]. Finally, de-
protonation of the C-22 cation by SHC yields cyclization
products (Figure 1A).
Analysis of 2.9 Aî and 2.0 Aî resolution three-dimensional
crystal structures for SHC revealed two K^K-barrel do-
mains that assemble to form a central hydrophobic cavity
[12,13]. These K-barrel domains are topologically distinct
from the single K-helical bundles that characterize the ses-
quiterpene cyclases [8]. Domain 1 is an K6^K6 barrel of
two concentric rings of parallel helices, while domain 2
appears to have evolved from domain 1 by gene duplica-
tion and loss of one of the helices [12]. SHC has a central
cavity of 1200 Aî 3, in which the catalysis is presumed to
take place.
Site-directed mutagenesis of Asp376 and Asp377 of the
SHC DDTAVV motif showed that both acidic residues
are required for catalysis [14]. Asp376 of SHC was pro-
posed to be the electrophilic residue that initiated cycliza-
tion by protonating the terminal isopropylidene of squa-
lene, based on the three-dimensional structure of SHC
containing an inhibitor, N,N-dimethyldodecylamine N-ox-
ide, in the active site [12]. Although this DDTAVV motif is
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highly conserved in all SHCs [15], the role of this motif in
initiation has not been veri¢ed.
One orally active drug candidate, Ro48-8071, is both pho-
toactivatable and a potent inhibitor of both OSC and SHC
[16,17]. This radiolabeled drug photocovalently modi¢ed
Ala44 in Alicyclobacillus acidocaldarius SHC [18]. Molecular
modeling based on this result and the published crystal
structures [12,13] suggested that Ro48-8071 may bind at
the juncture between the central cavity and substrate en-
trance channel, thus inhibiting access of the substrate to
the active site [18]. This region, including Glu45, had been
postulated to be important in the termination of cyclization
[12,18].
Combining studies of enzyme inhibition, product analyses
for mutants and alternative substrates, and the availability
of 2.9 Aî and 2.0 Aî resolution crystal structures of SHC
[12,13] now permits targeted approaches to identify resi-
dues involved in catalysis. We describe herein product
analyses for SHC mutants that implicate speci¢c functions
in substrate selectivity and cyclization initiation for the
DDTAVV motif, and cyclization termination for Glu45.
Results
The DDTAVV motif in bacterial SHCs is homologous to
the conserved DCTAEA motif in plant, yeast, and verte-
brate OSCs, and is crucial for cyclase activity [14,19,20]. To
test the role of this motif in cyclization, we altered the
DDTAVV motif to DCTAEA by preparing a D377C/
V380E/V381A triple mutant. This SHC triple mutant was
photocovalently labeled by [3H]Ro48-8071 (Figure 2), but
cyclization of squalene could not be detected in incubation
when assayed at 35‡C to 70‡C (see Table 1). Absence of
squalene cyclase activity is consistent with the observation
that the D377E mutant of SHC had only 0.04% wild-type
(wt) activity [14].
Interestingly, however, this triple mutant of SHC showed
signi¢cant cyclization of [14C]2,3-oxidosqualene as de-
tected by radio-thin layer chromatography (radio-TLC).
Since wt SHC was known to cyclize both enantiomers of
OS to give the diastereomeric hop-22(29)-en-3-ols as prod-
ucts [21,22], a preparative incubation of (3RS)-OS with Es-
cherichia coli cell lysate for the triple mutant was performed.
Gas chromatographic (GC) analysis showed the presence of
four cyclization products with retention times (rt) of 12.7,
12.8, 31.0, and 32.3 min. Puri¢cation to homogeneity on
SiO2 afforded isolated yields of 10% (for the two materials
at 12.7 and 12.8 min), and 10% each for the longer rt
products; unreacted substrate was also recovered. The
products at 31.0 and 32.2 min were determined to be the
diastereomers of hop-22(29)-en-3-ol by high resolution
mass spectroscopy (HRMS; calcd. 426.3862, found
426.3864 and 426.3866, respectively), low resolution mass
spectroscopy (LRMS; 70 eV, database from mass spectros-
copy facility), and nuclear magnetic resonance (NMR; 500
MHz, CDCl3) [23^25]. Speci¢cally, diagnostic chemical
shift and coupling patterns for H-3 at either N 3.12 (dd,
J = 11, 4.5 Hz, 1H) or 3.32 (m, 1H) supported the 3L-ol
(6b) and 3K-ol (6a) assignments for the longer and shorter
rt fractions, respectively. In addition, the angular methyls
at N 0.69 (s, 3H, 4L-Me) and 0.86 (s, 3H, 4K-Me) in 6b shift
to N 0.76 and 0.87 in 6a.
Figure 1. Cyclization by wt and mutant SHC. (A) Cyclization of squalene (1) to hop-22(29)-ene (2) and hopan-22-ol (3) by wt SHC.
(B) Cyclization of (3RS)-2,3-OS by SHC mutant D377C/V380E/V381A with conversion to hop-22(29)-en-3K-ol (6a) or 3L-ol (6b) and
3K-achilleol A (7a) or achilleol A (7b).
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The two compounds at rt 12.7 and 12.8 min could not be
resolved chromatographically and were examined as a mix-
ture. HRMS indicated the formula C30H50O (calcd.
426.3862, found 426.3868) for both isomers. The presence
of exo-methylene groups and trisubstituted alkene vinyl
protons indicated that incomplete cyclization had occurred.
Comparison of the NMR data of 1H, 1H^1H COSY,
HMQC at 500 MHz with literature data [26,27], in con-
junction with LRMS fragmentation patterns (70 eV), allows
structural assignment as the diastereomeric compounds
achilleol A (7b, Figure 1B) and 3K-achilleol A (7a, Figure
1B). Since wt SHC cyclized squalene into hop-22(29)-ene
and gave hopan-22-ol as byproduct, hopan-3,22-diol could
conceivably be produced as a minor product from (3RS)-
OS by either wt or mutant SHC [21]; however, no diol
products were detected.
To determine which residues could account for the change
of the substrate speci¢city and the interruption of the cy-
clization at the monocyclic stage, single mutations of
D377C, V380E, and V381E were also constructed, tested,
and the cyclization products were analyzed by GC. When
squalene was tested as substrate, D377C had negligible
activity, but both V380E and V381A had cyclase activity
comparable to that of wt SHC. When using OS as sub-
strate, all three single mutants cyclized OS into hop-
22(29)-en-3-ols. Interestingly, no achilleol A or 3K-achilleol
A was detected as product for V380E and V381A, while
traces of monocyclic products were detected for D377C.
Four single-point mutants of SHC (E45A, E45D, E45K
and E45Q) were constructed, expressed, puri¢ed and as-
sayed. Table 1 shows the enzymatic activity of the wt
enzyme and four mutants at 60‡C, the optimal temperature
for wt SHC. The E45A mutant retained 6% wt activity,
while the E45K mutant showed no detectable activity.
Shortening the side chain of the Glu residue to Asp in
E45D resulted in 42% wt activity. Most intriguingly, re-
placement of the glutamate with a glutamine in E45Q gave
118% wt activity. On the other hand, Km values of wt and
mutants for squalene were essentially the same as that
previously reported for wt SHC [28], indicating that the
mutation of E45 did not affect the binding of squalene.
Thus, the difference of the activity observed for mutants
suggested the catalytic role of Glu45 (Table 1). Each of the
mutants was ef¢ciently labeled by [3H]Ro48-8071, regard-
less of catalytic activity, also suggesting that the SHC mu-
tants are all properly folded (Figure 2).
SHC cyclizes squalene into hop-22(29)-ene (2) and hopan-
22-ol (3) (Figure 1A). Analysis of the products by capillary
GC (Table 1) revealed that more hopanol (3) is formed
relative to hopene (2) for E45A and E45D mutants in
comparison to wt and E45Q. This supports an earlier sug-
gestion that Glu45 could be involved in stabilization of a
C-22 carbocation intermediate [12,13,18]. That is, as in
E45A and E45D, the absence of stabilization of the termi-
nal cation by an appropriately positioned nucleophilic
group facilitates quenching of the cyclization by water,
while the E45Q permits stabilization to achieve a normal
production ratio. Importantly, the complete lack of activity
of E45K suggests that the reversal of charge near the ter-
Figure 2. Fluorogram illustrating photoaf¢nity labeling of SHC
mutants with [3H]Ro48-8071. Equal amounts of proteins were
loaded into each lane after irradiation [17]. After SDS^PAGE
separation, labeled protein was visualized by £uorography.
Lane 1, E45A; lane 2, E45D; lane 3, E45K; lane 4, E45Q;
lane 5, D377C/V380E/V381A.
Table 1
Properties of SHC mutants. Squalene was used as substrate and all activity was compared to wt SHC.
SHC Relative activity at 60³C (% wt) Km (WM) Optimal temperature (³C) Ratio of 2:3
wt 100.0 4.0 60 7.6
E45A 5.9 4.5 50 3.6
E45D 42.2 4.1 50 4.1
E45K N.A. n.d. tr n.d.
E45Q 118.3 4.6 55 8.3
D377C/V380E/V381A N.A. n.d. N.A. n.d.
N.A., no detectable activity; n.d., not determined; tr, traces of pentacyclic products at lower temperatures.
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mination of cyclization would remove an important source
of carbocation stabilization and quenching, and thus pre-
vent cyclization from being initiated.
Temperature pro¢les for cyclization by mutant and wt
SHCs were obtained by measuring squalene cyclization
at 35, 40, 50, 60, 65, and 70‡C. Incubation times were
adjusted to give equivalent net conversion to product. As
indicated in Table 1 and Figure 3, both E45A and E45D
showed maximal activity at 50‡C, which was 10‡C lower
than for wt SHC.
Discussion
The acidic residues Asp376 and Asp377 are crucial resi-
dues for SHC activity [14,19,20], but the identity of the
residue likely to initiate cyclization by isopropylidene pro-
tonation is still in question. Cyclization of OS, but not
squalene, by the triple mutant D377C/V380E/V381A offers
strong support for protonation of the epoxide by Asp376.
The higher resolution SHC structure shows two H-bonded
pairs present in proximity to each other: Asp376:His451
and Asp374:Asp377 (Figure 4) [12]. It appears that the
negative charge borne by Asp374:Asp377 stabilizes the
positive charge on Asp376:His451 [12] (Figure 2), since
Asp alone may not have suf¢cient acidity to initiate the
cyclization [20]. The function of Asp376 in SHC could be
further enhanced by a proximal water molecule [13].
In the absence of this reinforcing interaction, as in the
triple mutant D377C/V380E/V381A, it seems that the pro-
tonated carboxylic acid of Asp376 alone is no longer able to
protonate an alkene. Nonetheless, consistent with the
Figure 3. Temperature vs. SHC activity
pro¢les for Glu45 mutants. Squalene was
used as the substrate and product analysis
was by GC.
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DCTAEA motif as a requirement for OSC function in
eukaryotic enzymes, the triple mutant can still initiate cy-
clization of OS by protonating the 2,3-epoxide. However,
due to the possible structural changes introduced by the
mutation of these three residues proximal to the initiation
site, the carbocationic intermediate appears to partition be-
tween complete cyclization and early termination (Figure
1B). This result lends support to the hypothesis that oxi-
rane ring cleavage and A-ring formation occur in a concerted
process [29^31]. On the other hand, the enzyme^substrate
complex involves many interactions, and even subtle dis-
turbance of the chaperoning effect can alter the cyclization
process. For example, mutation of Ile481 in cycloartenol
synthase from Arabidopsis thaliana (homologous residue to
Asp374 in SHC) to Val481 generated lanosterol and par-
keol in addition to cycloartenol (the usual exclusive cycli-
zation product) in a ratio of 26:22:52 [32]. Interestingly,
mutation of Val454 in lanosterol synthase from Saccharomy-
ces cerevisiae (also homologous to Asp374 in SHC) to Ala or
Gly also gave achilleol A as a byproduct, in addition to
lanosterol [33]. These results with OSCs demonstrated
that small steric differences of these aliphatic residues
[32,33] could in£uence either ¢nal deprotonation (lanoste-
rol vs. cycloartenol) or continuation of cyclization. In a dif-
ferent approach, the N-terminal domain of a plant triter-
pene cyclase was found to be product-determining using
chimeric OSC constructs [34].
Although A-ring formation is most likely a concerted pro-
cess, the subsequent steps require stabilization of cationic
intermediates by aromatic or nucleophilic residues within
the active site. For example, mutation of the residues that
stabilize later intermediates, such as Y420A (Figure 4),
gave rise to bi- and tricyclic products [9,10]. Similarly, par-
tial cyclization to mono- and bicyclic products by wt SHC
was observed using 11-£uoro- and 14-£uoro-substituted OS
as substrates [35,36].
Alteration of the Z-cation stabilizing residues can also affect
the outcome of the cyclization. Thus, mutagenesis of three
conserved tyrosine residues (Tyr495, Tyr609, and Tyr612)
in A. acidocaldarius SHC was reported very recently, and
each Tyr residue was shown to be intimately involved in
the cyclization process [37]. Y612F had reduced activity
compared to wt SHC, while Y495F was essentially inac-
tive. However, both mutants gave the same product pat-
tern as wt SHC. In contrast, Y609F had an activity com-
parable to wt SHC, but one bicyclic and ¢ve tetracyclic
triterpenes were also isolated as cyclization products in
addition to hopene and hopanol. This result suggested
that Tyr609 contributed to the stabilization of carbocation
intermediate(s), and that the altered interaction with Phe
substitution led to early cyclization termination.
An independent report recently described a functional role
for the D374XDDTAVV381 motif during SHC cyclization
[38], in which mutagenesis data also supported the impor-
tance of Asp376 and His451 in cyclization initiation. On
the other hand, the authors argued that Asp377 acted to
stabilize C-10 carbocation intermediate (hopene number-
ing). However, this hypothesis appears not be consistent
with the three-dimensional active site structure, in partic-
ular the hydrogen bonding between Asp374 and Asp377
[12]. It is also inconsistent with the models previously
described [13].
While Asp376 and Asp377 are located deep within the
hydrophobic catalytic cavity, Glu45 is located near the sub-
Figure 4. Stereopairs illustrating the
residues that contribute to the initiation
(Asp374, Asp376, Asp377, His451) and
termination (Glu45, Glu93, Arg127) of
squalene cyclization by SHC. The positive
charge on Asp376:His451 is stabilized by
the negative charge from Asp374:Asp377
to initiate the cyclization. The carbocation
intermediate formed at the cyclization
termination is stabilized by a network
constituted by Gln262:Glu45:Glu93:Arg127.
For comparison, Trp489, Phe601, Tyr420,
and Trp169 are also shown; these
residues are reportedly involved in
stabilizing cyclization intermediates
[9,10,44].
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strate access or product exit channel (Figure 4) [12]. The
reduction of cyclization activity for E45D and E45A, and
the abrogation of cyclization activity for E45K, con¢rm a
role for Glu45 in the cyclization process. This residue,
which is conserved in all SHC sequences, provides a nu-
cleophilic group important in cyclization termination. This
is consistent with earlier ¢ndings that a hydrogen-bonding
network of Gln262:Glu45:Glu93:Arg127 involving also a
water molecule may stabilize or quench the C-22 carboca-
tion [12,13]. Although E45D has a carboxylate functional-
ity, its reduced activity showed that not only nucleophilic-
ity, but also positioning of the carboxylate group of Glu45,
was important. The enhanced activity of E45Q relative to
wt SHC is not as readily explained. In other enzymes for
which glutamic acid residues are purported to be respon-
sible for stabilization of carbocation intermediates, substi-
tution of glutamine generally decreased activity [39,40].
Examination of the interaction between the side chain of
Glu45 and proximal residues showed that hydrogen bond-
ing was limited to only one of the carboxylate oxygens
(with Arg127 and Glu93, see Figure 4). This H bond is
retained in E45Q. We conclude that, although Glu45 is
important in stabilizing the terminal carbocation, it may
not be the only residue involved in cyclization termination.
Signi¢cance
Although triterpene cyclization has been studied for many
years [1], detailed studies of the enzyme^substrate inter-
action were not possible until three-dimensional structures
of SHC became available [12,13]. Targeted mutations in
putative catalytic motifs conserved with different sequen-
ces in eukaryotic OSCs and prokaryotic SHCs reveal that
substrate selectivity for cyclization initiation resides in the
DCTAEA (OSC) or DDTAVV (SHC) motifs. Moreover, a
glutamic acid at the distal end of the cyclase active site
appears to provide subtle guidance of a water molecule in
the product determination step. Due to the similarity be-
tween OSC- and SHC-catalyzed cyclization, and absence
of a three-dimensional structure for OSC, rich information
can still be obtained from SHC. Such insight enhances
design of additional cholesterol-lowering and anti-fungal
drugs.
Materials and methods
Plasmid construction
A pUC19-derived plasmid encoding His6-tagged SHC from A. acidocal-
darius was used as template for the site-directed mutagenesis [14].
Mutated DNA was constructed by PCR ampli¢cation using Quik-
Change1 Site-Directed Mutagenesis Kit (Stratagene). The triple mutant
D377C/V380E/V381A was constructed by replacing GAC by TGC, GTC
by GAA, and GTG by GCG, respectively. Mutants of Glu45 are: E45A
(GAG to GCG), E45D (GAG to GAT), E45K (GAG to AAG), E45Q (GAG
to CAG). PCR ampli¢cation used 2.5 U Pfu DNA polymerase for
16 cycles (95³C, 45 s; 55³C, 1 min; 68³C, 15 min). A single DNA
band of 4.9 kb as PCR product was observed on agarose gel. After
cleavage of parent DNA by DpnI digestion, mutated DNA was cloned
into XL1 Blue cells. Mutated sequences were con¢rmed by DNA se-
quencing.
Expression and puri¢cation of mutants
Mutant proteins were puri¢ed as previously described [18,41]. Brie£y,
transformed cells were grown in LB medium containing 30 mg/l of am-
picillin overnight. Harvested cells were lysed by lysozyme or using a
French press, followed by solubilization of membrane proteins and
heat treatment at 60³C to denature and remove most E. coli proteins.
The heat denaturation step was omitted for temperature studies of cy-
clase activity and protein stability. Mutants were puri¢ed to homogeneity
by eluting from Ni-NTA agarose (Qiagen) with 125 mM imidazole in 50
mM Na-phosphate, 300 mM NaCl and 10% glycerol at pH 7.0.
Enzyme labeling and activity assay
Puri¢ed mutants were labeled by [3H]Ro48-8071 as previously de-
scribed [17]. For enzyme assay, 50 Wl puri¢ed SHC mutant was incu-
bated with [14C]squalene at 60³C for 45 min or 1 h. The reaction mixture
was extracted with CH2Cl2 and analyzed by TLC. GC was carried out
using an HP-5 capillary column (30 m, 0.32 mm i.d.) programmed at
250³C, 1 min; 5³C/min to 280³C; held at 280³C for 30 min.
Kinetic study
To measure kinetic parameters, 2, 4, 6, 8, or 10 WM [14C]squalene (¢nal
conc.) was added and incubated with appropriate amounts of enzymes
at 60³C for 1 h. The conversions of squalene to products were assayed
by TLC and plotted according to the method of Lineweaver and Burk
[42].
Substrate and product puri¢cation of the triple mutant
Oxidosqualene was prepared by treatment of squalene with N-bromo-
succinimide in tetrahydrofuran/H2O followed by reaction of bromohydrin
with K2CO3 in methanol [43]. E. coli cell lysate for the triple mutant was
incubated with (3RS)-OS at 50³C for 16 h. CH2Cl2 extract was puri¢ed
on silica gel with EtOAc:hexane (1:1) to remove Triton X-100. Oxido-
squalene and products were separated on silica gel, and products were
then puri¢ed by preparative TLC.
Spectroscopic data for achilleol A and 3K-achilleol A
For achilleol A, which has the 3L-con¢guration, the 1H NMR spectrum
showed N 4.72 (d, 1H, H-27a), 4.52 (d, 1H, H-27b), 3.59 (dd, J = 10.5,
4.5 Hz, 1H, H-3), 2.11 (m, 1H, H-1a), 1.82 (m, 1H, H-1b), 1.73 (m, 1H,
H-2a), 1.43 (m, 1H, H-2b), 0.96 (s, 3H, H-26), 0.65 (s, 3H, H-25). For
3K-achilleol A, signals were obtained at N 4.80 (d, 1H, H-27a), 4.54 (d,
1H, H-27b), 3.34 (m, 1H, H-3), 2.26 (m, 1H, H-1a), 1.93 (m, 1H, H-1b),
1.79 (m, 1H, H-2a), 1.58 (dd, 1H, H-5), 1.42 (m, 1H, H-2b), 0.91 (s, 3H,
H-26), 0.82 (s, 3H, H-25). LRMS showed characteristic fragment ion at
m/z 121 [C9H13].
Supporting information available
Experimental details including 1H NMR and LRMS of 6b (hop-22(29)-en-
3L-ol) and 6a (hop-22(29)-en-3K-ol); 1H NMR, 1H^1H COSY, HMQC
and LRMS of the mixture of 7b and 7a (achilleol A and 3K-achilleol A).
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